CelineBio is pioneering a novel approach to program and automate precision-targeted immunotherapies at scale to cure more patients and diseases at a lower cost. Our proprietary tech-bio platform integrates a high-throughput approach with generative AI, synthetic biology, and de novo protein engineering to drive the discovery and development of life-saving therapies.